A clinical study for men whose PSA is rising, despite having ongoing treatment for prostate cancer and whose cancer has not spread beyond the prostate. The purpose of this study is for doctors and researchers to evaluate the investigational medication ODM-201. They want to compare the safety and effectiveness of ODM-201 with that of placebo, which looks like ODM-201, but contains no active ingredients. The results of this study will provide more information about ODM-201 and whether it could one day be used to potentially treat men with prostate cancer that is at risk of progressing, but has not already spread to other areas of the body.

Learn More

Prostate cancer is a disease that is most successfully treated when it is detected early on.  As the research community explores various methods to detecting the disease, PCEC continues to encourage men to play an active role in their health by looking to those trusted sources of prostate cancer testing – the PSA and DRE.

~Dr. E. David Crawford
Head of the Urologic Oncology Department at the University of Colorado Health Sciences Center
Founder/Chairman of PCEC

Join Our Newsletter